
Daré Bioscience Investor Relations Material
Latest events

Q3 2024
Daré Bioscience
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Daré Bioscience Inc
Access all reports
Daré Bioscience Inc. is a biopharmaceutical company focused on developing and commercializing innovative products for women’s health. The company’s portfolio includes therapies aimed at addressing unmet needs in contraception, fertility, and sexual health. Daré’s products are designed to improve options for women by offering novel solutions in areas such as hormone-free contraception and treatments for female sexual disorders. The company is headquartered in San Diego, California, and its shares are listed on the NASDAQ.
Latest articles
)
Robert G. Hagstrom: Darwinian Investing and Multidisciplinary Wisdom
Robert G. Hagstrom, author of The Warren Buffett Way, explores how interdisciplinary thinking shapes his investing, from Adler's reading to Darwinian markets.
7 Feb 2025
)
Quartr Brings Stories Behind the Numbers to Light
Quartr simplifies access to IR material and puts qualitative insights and company narratives front and center.
3 Feb 2025
)
The Evolution of the IRO Role: Staying Informed and Strategic With Quartr Pro
Staying informed is critical for IROs. Quartr Pro simplifies gathering market insights and narrative positioning with unprecedented speed and precision.
3 Feb 2025
Ticker symbol
DARE
Country
🇺🇸 United States